S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in
OTCMKTS:AXIM

AXIM Biotechnologies Stock Forecast, Price & News

$0.58
-0.05 (-7.94 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.51
Now: $0.58
$0.68
50-Day Range
$0.41
MA: $0.61
$0.86
52-Week Range
$0.10
Now: $0.58
$1.44
Volume175,850 shs
Average Volume397,234 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
AXIM Biotechnologies, Inc. is a vertically integrated research and development company focused on changing diagnosis and treatment for oncology and SARS-CoV-2 (COVID-19). The company's NeuCovix is the rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells. It is developing rapid diagnostic tests for the early detection of cancer and proprietary small molecules drugs to treat cancer and block metastasis. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was founded in 2010 and is headquartered in San Diego, California.

Headlines

Axim Biotechnologies Inc
December 17, 2020 |  bloomberg.com
See More Headlines

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:AXIM
CUSIPN/A
Phone212-751-0001
Employees4
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.42 out of 5 stars

Medical Sector

1685th out of 1,969 stocks

Biotechnology Industry

92nd out of 125 stocks

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.58
-0.05 (-7.94 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AXIM News and Ratings via Email

Sign-up to receive the latest news and ratings for AXIM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AXIM Biotechnologies (OTCMKTS:AXIM) Frequently Asked Questions

What stocks does MarketBeat like better than AXIM Biotechnologies?

Wall Street analysts have given AXIM Biotechnologies a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AXIM Biotechnologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting AXIM Biotechnologies?

AXIM Biotechnologies saw a increase in short interest during the month of January. As of January 29th, there was short interest totaling 58,000 shares, an increase of 195.9% from the January 14th total of 19,600 shares. Based on an average trading volume of 443,400 shares, the short-interest ratio is currently 0.1 days.
View AXIM Biotechnologies' Short Interest
.

How has AXIM Biotechnologies' stock been impacted by Coronavirus (COVID-19)?

AXIM Biotechnologies' stock was trading at $0.1781 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, AXIM stock has increased by 225.6% and is now trading at $0.5799.
View which stocks have been most impacted by COVID-19
.

Who are AXIM Biotechnologies' key executives?

AXIM Biotechnologies' management team includes the following people:
  • Mr. John W. Huemoeller II, Pres, CEO & Director (Age 66, Pay $210k)
  • Mr. Robert T. Malasek, CFO & Sec. (Age 53, Pay $30k)
  • Dr. Sergei A. Svarovsky Ph.D., Chief Scientific Officer & Co-Founder of Sapphire Biotech
  • Dr. Douglas Lake Ph.D., Chief Clinical Officer of Sapphire Biotech
  • Dr. Alim Seit-Nebi Ph.D., CTO & Co-Founder of Sapphire Biotech
  • Ms. Catalina Valencia J.D., Chief Exec. Officer of Sapphire Biotech

Who are some of AXIM Biotechnologies' key competitors?

What other stocks do shareholders of AXIM Biotechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AXIM Biotechnologies investors own include (CGC), Cronos Group (CRON), (APHA), Tilray (TLRY), KushCo (KSHB), Aurora Cannabis (ACB), Curaleaf (CURLF), Charlotte's Web (CWBHF), Fulcrum Therapeutics (FULC) and Alibaba Group (BABA).

What is AXIM Biotechnologies' stock symbol?

AXIM Biotechnologies trades on the OTCMKTS under the ticker symbol "AXIM."

How do I buy shares of AXIM Biotechnologies?

Shares of AXIM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AXIM Biotechnologies' stock price today?

One share of AXIM stock can currently be purchased for approximately $0.58.

How many employees does AXIM Biotechnologies have?

AXIM Biotechnologies employs 4 workers across the globe.

What is AXIM Biotechnologies' official website?

The official website for AXIM Biotechnologies is aximbiotech.com.

How can I contact AXIM Biotechnologies?

The company can be reached via phone at 212-751-0001.


This page was last updated on 3/7/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.